Cargando…
Milnacipran poorly modulates pain in patients suffering from fibromyalgia: a randomized double-blind controlled study
INTRODUCTION: Fibromyalgia is characterized by widespread and chronic pain, and its prevalence is increasing worldwide. Milnacipran, an antidepressant, is often prescribed for fibromyalgia with a possible beneficial effect on central pain modulation. The aim of this study was to evaluate if milnacip...
Autores principales: | Pickering, Gisèle, Macian, Nicolas, Delage, Noémie, Picard, Pascale, Cardot, Jean-Michel, Sickout-Arondo, Sophia, Giron, Fatiha, Dualé, Christian, Pereira, Bruno, Marcaillou, Fabienne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089099/ https://www.ncbi.nlm.nih.gov/pubmed/30127596 http://dx.doi.org/10.2147/DDDT.S162810 |
Ejemplares similares
-
Fibromyalgia, milnacipran and experimental pain modulation: study protocol for a double blind randomized controlled trial
por: Macian, Nicolas, et al.
Publicado: (2015) -
Effect of ketamine combined with magnesium sulfate in neuropathic pain patients (KETAPAIN): study protocol for a randomized controlled trial
por: Delage, Noémie, et al.
Publicado: (2017) -
Short-Term Magnesium Therapy Alleviates Moderate Stress in Patients with Fibromyalgia: A Randomized Double-Blind Clinical Trial
por: Macian, Nicolas, et al.
Publicado: (2022) -
Milnacipran for the management of fibromyalgia syndrome
por: Ormseth, Michelle J, et al.
Publicado: (2010) -
Role and rationale for the use of milnacipran in the management of fibromyalgia
por: Kranzler, Jay D, et al.
Publicado: (2010)